Xeris Biopharma Holdings (XERS) EBIT Margin Growth (1y) (2021 - 2026)
Xeris Biopharma Holdings (XERS) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Xeris Biopharma Holdings | 1.48 Bn | 1.36 Bn | 79.59 Mn | -65.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -65.00 |
| Mar 31, 2026 | 1,466.00 |
| Dec 31, 2025 | 1,675.00 |
| Sep 30, 2025 | 3,281.00 |
| Jun 30, 2025 | 2,330.00 |
| Mar 31, 2025 | 2,991.00 |
| Dec 31, 2024 | 2,496.00 |
| Sep 30, 2024 | -1,359.00 |
| Jun 30, 2024 | 2,501.00 |
| Mar 31, 2024 | 494.00 |
| Dec 31, 2023 | 2,360.00 |
| Sep 30, 2023 | 5,301.00 |
| Jun 30, 2023 | 3,271.00 |
| Mar 31, 2023 | 9,172.00 |
| Dec 31, 2022 | 17,949.00 |
| Sep 30, 2022 | 15,706.00 |
| Jun 30, 2022 | 21,480.00 |
| Mar 31, 2022 | 7,255.00 |
| Dec 31, 2021 | 4,891.00 |
| Sep 30, 2021 | -7,402.00 |